Company / Total Assets
Edgewise Therapeutics, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$552.6M
FY2025
5-year range
$285.2M / $552.6M
FY2021-FY2025
Trend
+13.5%
vs FY2024
Sector context
#131 of 214
Health Care
What the data says
At $553M, Edgewise Therapeutics, Inc.'s total assets ranks #131 of 214 in the Health Care sector. Improved from $340M to $553M over the past 2 years.
Based on SEC 10-K filings.
$553M in FY2025 with a 5-year CAGR of +33.3%.
Improved from $340M to $553M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +14.6%
- 5-Year CAGR
- +33.3%
- 10-Year CAGR
- -
Sector benchmark
#131 of 214 in Health CareTop 61% of 214This company $552.6M Sector average $7.5B
▼
-92.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +33.3%, indicating consistent growth.
- In FY2025, total assets increased 13.5% year-over-year.
- Ranks #131 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $552.6M | +13.5% |
| FY2024 | $486.8M | +43.2% |
| FY2023 | $340.0M | -7.4% |
| FY2022 | $367.1M | +28.7% |
| FY2021 | $285.2M | +117.5% |
| FY2020 | $131.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026